TABLE 2.
IC50 determination of purified monoclonalsa
| MAbb | IC50 (μg/ml) for strain (subgroup):
|
|||
|---|---|---|---|---|
| NL100 (A1) | NL1700 (A2) | NL199 (B1) | NL194 (B2) | |
| 338 | 0.38 | 0.8 | 0.03 | 0.17 |
| 234 | 0.59 | 1.2 | 0.01 | 0.18 |
| 628 | 0.39 | 1.7 | 0.15 | 0.15 |
| 242 | 10.4 | 23.6 | 0.2 | 1.0 |
| 757 | 11.9 | 10.4 | 1.4 | 5.1 |
| 659 | 17.0 | 2.0 | 2.4 | 19.0 |
| 836 | 36.2 | 7.20 | 3.0 | 39.6 |
| 1017 | 16.7 | 38.4 | 12.8 | 29.6 |
| 967 | 0.15 | 0.15 | >100 | 4.8 |
| 710 | 33.8 | >100 | 2.4 | 16.4 |
| 344 | >100 | >100 | 0.8 | 24.0 |
| 1025 | 1.80 | 48.6 | >100 | >100 |
a
IC50 determinations were calculated as described in Materials and Methods.
b
MAbs in boldface type were isolated from more than one clone.